IP Library Granted Patent US 8,198,445
Granted Patent B2
US 8,198,445 · App. 12/530,287 · Granted Jun 12, 2012

Phosphoramide compound, method for producing the same, ligand, complex, catalyst and method for producing optically active alcohol

Assignees: National University Corporation Nagoya University; Sekisui Medical Co., Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,198,445
App. No.
12/530,287
Granted
Jun 12, 2012
Kind
B2
Abstract

Disclosed is a method for highly efficiently obtaining an optically active alcohol from a carbonyl compound highly enantioselectively. Also disclosed is a ligand used in such a method. Specifically, an optically active alcohol is obtained by reacting a carbonyl compound and an organozinc compound by using a ligand (L) shown below.

Claims (51)

1. A method for producing an optically active alcohol, comprising:

reacting a carbonyl compound with an organozinc compound in the presence of a phosphoramide compound,

wherein the carbonyl compound is one of an aldehyde compound and a ketone compound,

wherein the organozinc compound comprises a compound represented by general formula (11) or compounds represented by general formulae (12) and (13),

ZnR 10 R 11   (11)

ZnR 12 R 13   (12)

ZnR 14 R 15   (13)

wherein

R 10 and R 11 independently are monovalent hydrocarbon groups, and at least one of R 10 and R 11 is an alkyl group, alkenyl group or alkynyl group;

R 12 and R 13 independently are aryl group, arylalkyl group or arylalkenyl group; and

R 14 and R 15 independently are alkyl group, alkenyl group or alkynyl group, and the phosphoramide compound is represented by general formula (1) or (1′)

wherein

R 1 is an alkyl group having 1 to 8 carbon atoms, a phenyl group or an optionally substituted benzyl group;

R 2 and R 3 independently are a phenyl group, a naphthyl group, a cyclohexyl group or an aryl group having 6 to 15 carbon atoms that may have a substituent;

R 4 and R 5 independently are an alkyl group having 1 to 8 carbon atoms or may be bonded together to form a five-to-eight membered saturated ring with a nitrogen atom to which R 4 and R 5 are attached, where the ring may have a hetero atom in the ring;

X is an oxygen atom; and

B is a methylene group or carbonyl group.

2. The method for producing an optically active alcohol according to claim 1 , wherein said phosphoramide compound is added in an amount in the range from 0.1% to 20% by mol based on said carbonyl compound.

3. The method for producing an optically active alcohol according to claim 1 , wherein said carbonyl compound is a ketone compound represented by general formula (14) or (15):

wherein

R 16 is a monovalent hydrocarbon group having three or more carbon atoms;

R 17 is a monovalent hydrocarbon group different from R 16 ; n is an integer of two or more; and

the aromatic ring of the general formula (15) may have a substituent.

4. The method for producing an optically active alcohol according to claim 1 , wherein an equivalent ratio of said organozinc compound represented by general formula (12) to said organozinc compound represented by general formula (13) is 1:(1 to 5).

5. A method for producing an optically active alcohol, comprising:

reacting a carbonyl compound with an organozinc compound in the presence of a ligand,

wherein the carbonyl compound is one of an aldehyde compound and a ketone compound,

wherein the organozinc compound comprises a compound represented by general formula (11) or compounds represented by general formulae (12) and (13),

ZnR 10 R 11   (11)

ZnR 12 R 13   (12)

ZnR 14 R 15   (13)

wherein

R 10 and R 11 independently are monovalent hydrocarbon groups, and at least one of R 10 and R 11 is an alkyl group, alkenyl group or alkynyl group;

R 12 and R 13 independently are aryl group, arylalkyl group or arylalkenyl group; and

R 14 and R 15 independently are alkyl group, alkenyl group or alkynyl group, and the ligand is represented by general formula (8a), (8b), (9a) or (9b):

wherein

R 1 to R 3 and R 7 independently are monovalent hydrocarbon groups;

R 2 and R 3 are each bound to a phosphorus atom directly or via an atom other than carbon atom;

R 6 is a hydrogen atom or a monovalent hydrocarbon group;

X is an oxygen atom or sulfur atom; and

B is a methylene group or carbonyl group.

6. The method according to claim 5 ,

wherein said reacting is performed in the presence of a complex comprising the ligand and a zinc atom.

7. The method according to claim 6 , for

wherein said reacting is performed in the presence of a catalyst comprising the complex.

8. The method according to claim 1 , wherein the reacting is performed in the presence of a complex or a catalyst comprising the complex, and the complex comprises the phosphoramide compound and a zinc atom.

9. The method according to claim 1 , wherein the carbonyl compound is an aldehyde compound.

10. The method according to claim 1 , wherein the carbonyl compound is a ketone compound.

11. The method according to claim 1 , wherein R 2 and R 3 independently are an alkoxyphenyl group or a halogenated alkylphenyl group.

12. The method according to claim 5 , wherein the carbonyl compound is an aldehyde compound.

13. The method according to claim 5 , wherein the carbonyl compound is a ketone compound.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 7, 2009
From: ISHIHARA, KAZUAKI; HATANO, MANABU; MIYAMOTO, TAKASHI
To: NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY; SEKISUI MEDICAL CO., LTD.
Reel/Frame 023612/0247 →
Priority Claims (1)
JP 2007-061030 · Mar 9, 2007 · national
Continuity (1)
Related Publication 20100113786A1 · May 6, 2010